# Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

- Source: PR Newswire M&A
- Published: 2026-11-05T21:10:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/amphastar-pharmaceuticals-reports-financial-results-for-the-three-months-ended-september-30-2026-302931249.html
- Canonical: https://groundlevelnews.com/story/amphastar-pharmaceuticals-reports-financial-results-for-the-three-mont-1daab0/

Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call today at 2:00...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._